UNSPSC 85511108: Supplement left external iliac artery with synthetic substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left external iliac artery with synthetic substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UJ0JZ

UNSPSC 85511108 Supplement left external iliac artery with synthetic substitute, open approach is a Commodity code that nominally describes a surgical vascular procedure, but the recent state and local contract opportunities tagged under this code bear no relationship to the code's stated scope. The opportunities posted under this code are instead healthcare service procurements — inmate medical and pharmacy services, pharmacy benefit management, virtual primary and urgent care, peer support services for mental health workers, and fire department medical direction — none of which involve vascular surgery or synthetic arterial supplements. The mismatch between the code's medical procedure title and the actual procurement activity suggests either a cataloging error in the source data or a systematic misalignment in how this code is being applied at the jurisdiction level. State and local governments do not appear to be using this code to solicit or award vascular surgical supplies or services.

The issuing bodies posting opportunities under this code include county governments (Muscogee County, Georgia; Collier County, Florida; Monroe County, Florida; San Mateo County, California) and municipal fire departments (Santa Monica, California). Geographic activity concentrates in Florida and California, with additional activity in Georgia. No recent opportunities specifically procure the vascular surgical product or service that the code nominally describes. Given the absence of relevant activity aligned with the code's actual scope, this code does not warrant pursuit for firms offering vascular medical devices, implants, or surgical services to state and local health systems.